LEO Pharma Joins Prasco Family of Brand Partners
CINCINNATI, OH; /August 8, 2012/— Prasco Laboratories will immediately begin distributing the Authorized Generic of Dovonex® (Calcipotriene) Cream, 0.005% in 60 gram and 120 gram tubes through a new distribution agreement with LEO Pharma A/S Calcipotriene Cream will be sold under the Prasco label.
“Prasco’s Calcipotriene Cream represents an alternative choice for patients and pharmacists who are looking for a product that is identical to Dovonex® Cream that competes with generics,” said Chris Arington, CEO of Prasco.
The agreement is the first between the two companies and adds LEO Pharma to Prasco’s family of partners. Prasco has launched more Authorized Generics than any other company.
“Prasco Authorized Generics bring a reliable supply of brand-quality drugs at an affordable cost,” Arington said. “Lifecycle management solutions such as this are helping companies such as LEO Pharma to provide more options to their patients.”
Calcipotriene Cream is AB-rated, therapeutically equivalent and substitutable for the brand Dovonex® Cream 0.005%. For additional information about Calcipotriene Cream, click here to see full prescribing information, or visit www.prasco.com.
About Prasco Laboratories – Prasco is the privately held pharmaceutical company located in Mason, Ohio, that specializes in providing product lifecycle management solutions such as Authorized Generics to Brand pharmaceutical companies. Prasco Authorized Generics provide patients with the identical brand drug experience, at a price that competes with generics. Moreover, Prasco Authorized Generics simplify interactions between pharmacists and consumers because they are identical to branded drugs. For more information, visit www.prasco.com.
About LEO Pharma – Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. The company has its own sales forces in 61 countries and employs more than 4,600 employees worldwide. LEO Pharma is headquartered in Denmark and is wholly owned by the LEO Foundation. For more information about LEO Pharma, visit www.leo-pharma.com.